Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Durham

Showing results (201-210 of 240) with videos related to

Pageof 24
Sort By:
Allergy|November 15, 2011
Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapyM H Shamji, C Ljørring, J N Francis, et al.
Allergy|March 12, 2015
Inhibition of allergen-dependent IgE activity by antibodies of the same specificity but different classT S Dodev, H Bowen, M H Shamji, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 6, 2006
Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challengeE M Erin, A S Zacharasiewicz, G C Nicholson, et al.
Allergy|March 17, 2015
Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challengeG W Scadding, A O Eifan, M Lao-Araya, et al.
Allergy|November 4, 2005
Single dose topical corticosteroid inhibits IL-5 and IL-13 in nasal lavage following grass pollen challengeE M Erin, B R Leaker, A S Zacharasiewicz, et al.
Allergy|November 19, 2017
A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapyR Mösges, E M Kasche, E Raskopf, et al.
Allergy|March 8, 2018
Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trialR Mösges, C Bachert, P Panzner, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 16, 2004
Characteristics of patients with seasonal allergic rhinitis and concomitant asthmaJ Bousquet, H A Boushey, W W Busse, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 25, 2006
Effects of a reversible beta-tryptase and trypsin inhibitor (RWJ-58643) on nasal allergic responsesE M Erin, B R Leaker, A Zacharasiewicz, et al.
European Journal of Immunology|February 17, 1998
Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cellsS Ying, D S Robinson, Q Meng, et al.
Pageof 24

Showing results (201-210 of 240) with videos related to

Sort By:
Pageof 24
Allergy|November 15, 2011
Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapyM H Shamji, C Ljørring, J N Francis, et al.
Allergy|March 12, 2015
Inhibition of allergen-dependent IgE activity by antibodies of the same specificity but different classT S Dodev, H Bowen, M H Shamji, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 6, 2006
Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challengeE M Erin, A S Zacharasiewicz, G C Nicholson, et al.
Allergy|March 17, 2015
Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challengeG W Scadding, A O Eifan, M Lao-Araya, et al.
Allergy|November 4, 2005
Single dose topical corticosteroid inhibits IL-5 and IL-13 in nasal lavage following grass pollen challengeE M Erin, B R Leaker, A S Zacharasiewicz, et al.
Allergy|November 19, 2017
A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapyR Mösges, E M Kasche, E Raskopf, et al.
Allergy|March 8, 2018
Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trialR Mösges, C Bachert, P Panzner, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 16, 2004
Characteristics of patients with seasonal allergic rhinitis and concomitant asthmaJ Bousquet, H A Boushey, W W Busse, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 25, 2006
Effects of a reversible beta-tryptase and trypsin inhibitor (RWJ-58643) on nasal allergic responsesE M Erin, B R Leaker, A Zacharasiewicz, et al.
European Journal of Immunology|February 17, 1998
Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cellsS Ying, D S Robinson, Q Meng, et al.
Pageof 24